Paper Details

  1. Home
  2. Paper Details

Efficacy and tolerance of nifedipine retard vs acebutolol in patients with essential hypertension treated for 26 weeks.

Author: BednarzB, CeremuzyńskiL, ChamiecT, KłośJ, PietrzykowskaH, ZaleskaT

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Nifedipine Retard and Acebutolol, antihypertensive drugs, were compared in patients with essential hypertension. Both drugs effectively reduced blood pressure, but Nifedipine Retard caused fewer side effects and less drop-outs.
Paper Details　
Original Abstract of the Article :
Patients with essential hypertension were given calcium channel antagonist, Nifedipine Retard or Acebutolol for 26 weeks in a single blind, randomised trial. Both drugs reduced mean systolic and diastolic blood pressure, but side effects were less frequent and caused less drop-outs in Nifedipine tha...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/2634218

データ提供：米国国立医学図書館（NLM）

Hypertension: Navigating the Desert of High Blood Pressure

This research delves into the complex world of hypertension, a common condition that affects millions of people worldwide. It's like a vast desert landscape, where the pressure is high and the terrain is unforgiving. This study focuses on comparing two different medications used to treat hypertension: nifedipine retard, a calcium channel blocker, and acebutolol, a beta-blocker. It's like exploring two different paths through the desert, seeking the most effective route to manage blood pressure.

Nifedipine Retard: A Smooth Desert Journey

The study found that both medications effectively reduced blood pressure, but nifedipine retard had fewer side effects and resulted in fewer patients dropping out of the study. It's like a camel with a smooth gait, navigating the desert comfortably without any complications. This suggests that nifedipine retard might be a more tolerable option for many patients, providing a smoother journey through the desert of hypertension.

Choosing the Right Path in the Desert

This research provides valuable insights for healthcare professionals and patients in choosing the most appropriate treatment for hypertension. It's like having a guide to help navigate the desert, ensuring a safe and comfortable journey. By understanding the comparative benefits and drawbacks of different medications, individuals can make informed decisions about their treatment and manage their hypertension effectively.

Dr.Camel's Conclusion

This study underscores the importance of finding the right medication for managing hypertension, emphasizing the individual nature of each patient's desert journey. Nifedipine retard, with its smoother ride through the desert, offers a promising option for many individuals struggling with this condition. This research serves as a valuable guide for healthcare professionals, helping them make informed decisions and improve the quality of life for their patients.

Date :
  1. Date Completed 1990-05-31
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

2634218

DOI: Digital Object Identifier

2634218

Related Literature

Article Analysis
・Side Effects of acebutolol
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.